MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice
Jingyi Pan,* Xinyu Li,* Xinyang Wang, Lili Yang, Houlin Chen, Nana Su, Chenghua Wu, Yu Hao, Shengwei Jin, Hui Li Department of Anaesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s R...
Guardado en:
Autores principales: | Pan J, Li X, Wang X, Yang L, Chen H, Su N, Wu C, Hao Y, Jin S, Li H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/973ca06bcb83494bbcf20fd4d18e21f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
por: Cao X, et al.
Publicado: (2021) -
Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation
por: Persson HL, et al.
Publicado: (2020) -
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
por: Michalski JE, et al.
Publicado: (2021) -
ANATOMY OF THE FISSURES PRESENT IN THE LUNG AND THEIR CLINICAL IMPORTANCE
por: Srijit Das
Publicado: (2021) -
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Jennifer L Taylor-Cousar, et al.
Publicado: (2010)